PRTA
PROTHENA CORP PUBLIC LTD CO
Next earnings Aug 3, 2026 · consensus $-0.14 EPS, $44.0M rev
Last earnings -5.9% on 2026-05-07
$10.02
▲ +8.09%$10.02▲ +65.35%
over 1Y
L $5.99EODHDH $11.51
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+8.1%
1W+9.5%
1M-0.1%
3M+8.2%
YTD+8.9%
1Y+65.3%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Conservative balance sheet (liabilities/equity 0.17x); but revenue fell -92.8% YoY.
Revenue (FY2025) $9.68M · FY2025
PROTHENA CORP PUBLIC LTD CO shows $9.68M in FY2025 revenue (-92.8% YoY), a -2520.6% net margin, and -87.0% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $201M | $53.9M | $91.4M | $135M | $9.68M |
| Gross profit | — | — | — | — | — |
| Operating income | $72.0M | -$132M | -$191M | -$155M | -$215M |
| Net income | $67.0M | -$117M | -$147M | -$122M | -$244M |
| Diluted EPS | $1.38 | -$2.47 | -$2.76 | -$2.27 | -$4.53 |
| Net margin | 33.4% | -217.0% | -160.9% | -90.5% | -2520.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$232M
EV / EBITDA—
EV / Sales23.9
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-45.3%
FCF yield—
Quality & risk
ROIC (est.)-60.5%
Free cash flow—
Total debt—
Net cash$308M
Altman Z-Score0.09 distress
Piotroski F-Score1/7
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-162026-06-18open ↗4Period ending 2026-06-152026-06-16open ↗4Period ending 2026-06-112026-06-12open ↗3Period ending 2026-06-082026-06-12open ↗144Filing2026-06-09open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-022026-06-03open ↗4Period ending 2026-05-222026-05-26open ↗4Period ending 2026-05-152026-05-15open ↗4Period ending 2026-05-152026-05-15open ↗4Period ending 2026-05-152026-05-15open ↗4Period ending 2026-05-152026-05-15open ↗
Frequently asked
- Is PROTHENA CORP PUBLIC LTD CO (PRTA) a buy?
- PRTA currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.17x); but revenue fell -92.8% YoY.
- What is PROTHENA CORP PUBLIC LTD CO's quality score?
- PRTA scores 31/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001559053, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 6:18:46 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.